Followers | 9 |
Posts | 998 |
Boards Moderated | 0 |
Alias Born | 04/05/2013 |
Saturday, September 23, 2017 3:42:22 PM
I'm a long of many years and so am very wary of being overly optimistic. There is no foundation for a good valuation for the company without revenue (obviously).
However, what I suspect will happen is that this uptrend will correspond with revenues, and that the uptrend predicts revenues. Anyone buying now is doing so in the expectation that the company will soon sign something. Since I suspect the timeline for that is about 3 months (before the end of the year, I suspect), that will likely be within the expectations of those buying now.
However, if it drags out to six months or more, then I would indeed expect a bunch of disappointed selling.
Or maybe the patience of current buyers is not as long as I predict (about 3 months). Maybe it's only one month, in which case by sometime in November it could start to tank. Who the heck knows.
Recent QSEP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 08:39:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 01:05:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:52:03 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM